
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
Nicoletta Plotegher, G Berti, Emanuele Ferrari, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 127
Nicoletta Plotegher, G Berti, Emanuele Ferrari, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 127
Showing 1-25 of 127 citing articles:
13 reasons why the brain is susceptible to oxidative stress
James N. Cobley, Maria Luisa Fiorello, Damian M. Bailey
Redox Biology (2018) Vol. 15, pp. 490-503
Open Access | Times Cited: 945
James N. Cobley, Maria Luisa Fiorello, Damian M. Bailey
Redox Biology (2018) Vol. 15, pp. 490-503
Open Access | Times Cited: 945
Oxidative stress and cellular pathologies in Parkinson’s disease
Lesly Puspita, Sun Young Chung, Jae‐Won Shim
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 415
Lesly Puspita, Sun Young Chung, Jae‐Won Shim
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 415
Alpha-synuclein oligomers: a new hope
Nora Bengoa‐Vergniory, Rosalind F. Roberts, Richard Wade‐Martins, et al.
Acta Neuropathologica (2017) Vol. 134, Iss. 6, pp. 819-838
Open Access | Times Cited: 316
Nora Bengoa‐Vergniory, Rosalind F. Roberts, Richard Wade‐Martins, et al.
Acta Neuropathologica (2017) Vol. 134, Iss. 6, pp. 819-838
Open Access | Times Cited: 316
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
Maria Nguyen, Yvette C. Wong, Daniel Ysselstein, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 2, pp. 140-149
Open Access | Times Cited: 270
Maria Nguyen, Yvette C. Wong, Daniel Ysselstein, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 2, pp. 140-149
Open Access | Times Cited: 270
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 268
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 268
The physiological role of α‐synuclein and its relationship to Parkinson’s Disease
David Sulzer, Robert H. Edwards
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 475-486
Open Access | Times Cited: 254
David Sulzer, Robert H. Edwards
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 475-486
Open Access | Times Cited: 254
Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani, Stefania Nicolis, Simone Dell’Acqua, et al.
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 20, pp. 6512-6527
Closed Access | Times Cited: 217
Enrico Monzani, Stefania Nicolis, Simone Dell’Acqua, et al.
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 20, pp. 6512-6527
Closed Access | Times Cited: 217
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
Jiaming Zhang, Xiaoping Li, Jia‐Da Li
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 166
Jiaming Zhang, Xiaoping Li, Jia‐Da Li
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 166
Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 88
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 88
Role of dopamine in the pathophysiology of Parkinson’s disease
Zhidong Zhou, Ling Yi, Qing Wang, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 75
Zhidong Zhou, Ling Yi, Qing Wang, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 75
Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
Sasanka Chakrabarti, Marco Bisaglia
Antioxidants (2023) Vol. 12, Iss. 4, pp. 955-955
Open Access | Times Cited: 49
Sasanka Chakrabarti, Marco Bisaglia
Antioxidants (2023) Vol. 12, Iss. 4, pp. 955-955
Open Access | Times Cited: 49
Key genes and convergent pathogenic mechanisms in Parkinson disease
Robert Coukos, Dimitri Krainc
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 6, pp. 393-413
Closed Access | Times Cited: 26
Robert Coukos, Dimitri Krainc
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 6, pp. 393-413
Closed Access | Times Cited: 26
α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson’s disease model
Tomoyuki Taguchi, Masashi Ikuno, Mari Hondo, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 249-265
Open Access | Times Cited: 94
Tomoyuki Taguchi, Masashi Ikuno, Mari Hondo, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 249-265
Open Access | Times Cited: 94
Adrianne F. Pike, Tatiana Varanita, Maaike A. C. Herrebout, et al.
Glia (2021) Vol. 69, Iss. 6, pp. 1413-1428
Open Access | Times Cited: 82
Monoamine oxidases in age-associated diseases: New perspectives for old enzymes
Yohan Santin, Jessica Resta, Angelo Parini, et al.
Ageing Research Reviews (2021) Vol. 66, pp. 101256-101256
Open Access | Times Cited: 73
Yohan Santin, Jessica Resta, Angelo Parini, et al.
Ageing Research Reviews (2021) Vol. 66, pp. 101256-101256
Open Access | Times Cited: 73
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
Nelson de Oliveira Manzanza, Lucia Sedlackova, Raj N. Kalaria
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 57
Nelson de Oliveira Manzanza, Lucia Sedlackova, Raj N. Kalaria
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 57
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Adrianne F. Pike, Francesca Longhena, Gaia Faustini, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 52
Adrianne F. Pike, Francesca Longhena, Gaia Faustini, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 52
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
Rachel M. Wise, Annika Wagener, Urban M. Fietzek, et al.
Neurobiology of Disease (2022) Vol. 175, pp. 105920-105920
Open Access | Times Cited: 47
Rachel M. Wise, Annika Wagener, Urban M. Fietzek, et al.
Neurobiology of Disease (2022) Vol. 175, pp. 105920-105920
Open Access | Times Cited: 47
Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease
D. J. Vidyadhara, Mahalakshmi Somayaji, Nigel Wade, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112231-112231
Open Access | Times Cited: 32
D. J. Vidyadhara, Mahalakshmi Somayaji, Nigel Wade, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112231-112231
Open Access | Times Cited: 32
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, et al.
CNS Drugs (2023) Vol. 37, Iss. 5, pp. 399-440
Open Access | Times Cited: 32
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, et al.
CNS Drugs (2023) Vol. 37, Iss. 5, pp. 399-440
Open Access | Times Cited: 32
Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disorder
Sunil Kumar, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6908-6917
Open Access | Times Cited: 29
Sunil Kumar, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6908-6917
Open Access | Times Cited: 29
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
Anna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Anna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Marika Alborghetti, Ferdinando Nicoletti
Current Neuropharmacology (2018) Vol. 17, Iss. 9, pp. 861-873
Open Access | Times Cited: 81
Marika Alborghetti, Ferdinando Nicoletti
Current Neuropharmacology (2018) Vol. 17, Iss. 9, pp. 861-873
Open Access | Times Cited: 81
Subcellular localization of alpha-synuclein aggregates and their interaction with membranes
Emanuela Colla, Fabiana Miraglia, Alessio Ricci, et al.
Neural Regeneration Research (2018) Vol. 13, Iss. 7, pp. 1136-1136
Open Access | Times Cited: 69
Emanuela Colla, Fabiana Miraglia, Alessio Ricci, et al.
Neural Regeneration Research (2018) Vol. 13, Iss. 7, pp. 1136-1136
Open Access | Times Cited: 69
Dietary Antioxidants and Parkinson’s Disease
Hana Park, Amy Ellis
Antioxidants (2020) Vol. 9, Iss. 7, pp. 570-570
Open Access | Times Cited: 68
Hana Park, Amy Ellis
Antioxidants (2020) Vol. 9, Iss. 7, pp. 570-570
Open Access | Times Cited: 68